FCER2 and B-cell chronic lymphocytic leukemia: Thus, markers such as CD38, CD49d, CD20 and CD23 are associated with disease progression and overall survival; high expression of CD38 and CD49d often indicates a more aggressive form of CLL; CD20 and CD23 are used to help diagnose and monitor CLL, with their expression levels providing additional prognostic information [11].